COVID-19 Acute Respiratory Distress Syndrome
Conditions
Keywords
vaccination perception
Brief summary
SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high: According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19. To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.
Interventions
BEHAVIORALInterview
Face to face semi-directed interviews about perceptions, representations and experiences of Covid-19 vaccination, including six opened-questions
Sponsors
Centre Hospitalier Intercommunal Villeneuve Saint Georges
Centre Hospitalier Intercommunal Creteil
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Over 18 years of age * Patient with a scheduled appointment in consultation or at the vaccination centre * Not opposed to participation in the protocol
Exclusion criteria
* Patient under guardianship or curatorship * Patient unable to give free and informed consent * Patient under court protection * Patient without the cognitive capacity to ensure an interview
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Perceptions, representations and experiences of Covid-19 vaccination | 1 hour | Interview based on 6 opened questions |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Key elements to improve the medical discourse on vaccination | 1 hour | Interview based on 6 opened questions |
Countries
France
Outcome results
None listed